Bank of Montreal
GMAB icon

Bank of Montreal’s Genmab GMAB Stock Holding History

Bank of Montreal’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-62,600
Closed -$2.63M – 5185
2020
Q4 		$2.63M Buy
+62,600
New +$2.34M ﹤0.01% 1709

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of Montreal's GMAB Position: Q2 2026 in Review

Bank of Montreal reduced its Genmab (GMAB) stake by 1.2% in Q2 2026, selling an estimated $17.1K and leaving 52,043 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1910.

Bank of Montreal first reported a position in GMAB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.01M in Q3 2023. 202 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Bank of Montreal held 52,043 shares of Genmab worth $1.43M as of Q2 2026.
  • Bank of Montreal sold 645 Genmab shares in Q2 2026, an estimated $17.1K.
  • Genmab made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1910 holding.
  • Bank of Montreal first reported a position in Genmab in Q4 2019 and has held it in 27 quarters since.
  • Bank of Montreal's Genmab position peaked at $3.01M in Q3 2023.
  • 202 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.